FindTrial
Sign In

sputum biomarkers for identifying lung cancer in pulmonary nodules

sputum biomarkers for identifying lung cancer in pulmonary nodules

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17011661
Enrollment
Unknown
Registered
2017-06-14
Start date
2017-06-25
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Gold Standard:histopathologic examinations
Index test:DNA&#32
methylation,&#32
microrna

Sponsors

West China School of Medicine/West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients who underwent a routine thoracic CT examination in our hospital; (2) aged older than 18 years; (3)clinical diagnoses were confirmed with histopathologic examinations

Exclusion criteria

Exclusion criteria: (1) refused to participate our study; (2) have received treatment(e.g., surgery, chemotherapy, and radiotherapy)

Design outcomes

Primary

MeasureTime frame
DNA hypermethylation;microrna;—

Countries

China

Contacts

Public ContactLi Weimin

West China School of Medicine/West China Hospital, Sichuan University

Weimin003@163.com+86 18980601009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026